| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1127653096 |
| P356 | DOI | 10.1016/J.ENCEP.2020.05.006 |
| P932 | PMC publication ID | 7229964 |
| P698 | PubMed publication ID | 32425222 |
| P8299 | Semantic Scholar corpus ID | 218657208 |
| P2093 | author name string | Fabien Vinckier | |
| Fabrice Chrétien | |||
| Michael Blatzer | |||
| Marion Plaze | |||
| Etienne Simon-Loriere | |||
| Anne-Cécile Petit | |||
| Raphaël Gaillard | |||
| Arnaud Cachia | |||
| David Attali | |||
| P2860 | cites work | Hepatitis C Virus Entry Depends on Clathrin-Mediated Endocytosis | Q27473290 |
| Phenothiazine-derived antipsychotic drugs inhibit dynamin and clathrin-mediated endocytosis | Q30009226 | ||
| JC virus enters human glial cells by clathrin-dependent receptor-mediated endocytosis. | Q30326112 | ||
| Repurposing of clinically developed drugs for treatment of Middle East respiratory syndrome coronavirus infection | Q30419612 | ||
| Chlorpromazine-induced immunopathy: progressive increase in serum IgM. | Q33404635 | ||
| Screening of an FDA-approved compound library identifies four small-molecule inhibitors of Middle East respiratory syndrome coronavirus replication in cell culture | Q34058365 | ||
| Inhibitors of alphavirus entry and replication identified with a stable Chikungunya replicon cell line and virus-based assays | Q34113650 | ||
| Effects of antipsychotic drugs on cytokine networks | Q34133802 | ||
| Therapeutic use in psychiatry of phenothiazine of central elective action (4560 RP) | Q34536971 | ||
| Coronavirus cell entry occurs through the endo-/lysosomal pathway in a proteolysis-dependent manner. | Q35399141 | ||
| Mis-assembly of clathrin lattices on endosomes reveals a regulatory switch for coated pit formation | Q36233556 | ||
| Parenteral treatment of episodic tension-type headache: a systematic review | Q38179092 | ||
| Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus–Infected Pneumonia in Wuhan, China | Q84574466 | ||
| A Novel Coronavirus from Patients with Pneumonia in China, 2019 | Q86729469 | ||
| Targeting the Endocytic Pathway and Autophagy Process as a Novel Therapeutic Strategy in COVID-19 | Q90744915 | ||
| Nervous system involvement after infection with COVID-19 and other coronaviruses | Q91512172 | ||
| Complex Immune Dysregulation in COVID-19 Patients with Severe Respiratory Failure | Q93153123 | ||
| The acute treatment of migraine in adults: the american headache society evidence assessment of migraine pharmacotherapies | Q38323922 | ||
| Repurposing some older drugs that cross the blood-brain barrier and have potential anticancer activity to provide new treatment options for glioblastoma | Q38587724 | ||
| Brain distribution and kinetics of 11C-chlorpromazine in schizophrenics: Positron emission tomography studies | Q40739170 | ||
| Inhibition of HIV Infection of H9 Cells by Chlorpromazine Derivatives | Q41111716 | ||
| Protective effect of chlorpromazine on endotoxin toxicity and TNF production in glucocorticoid-sensitive and glucocorticoid-resistant models of endotoxic shock | Q41837133 | ||
| Interference in Japanese encephalitis virus infection of Vero cells by a cationic amphiphilic drug, chlorpromazine | Q43048066 | ||
| Influence of chlorpromazine on the replication of influenza virus in chick embryo cells. | Q43433487 | ||
| Chlorpromazine and apigenin reduce adenovirus replication and decrease replication associated toxicity | Q45864265 | ||
| Chlorpromazine specifically inhibits peripheral and brain TNF production, and up-regulates IL-10 production, in mice. | Q48117114 | ||
| The distribution and metabolism of chlorpromazine in rats and the relationship to effects on cerebral monoamine metabolism | Q48347675 | ||
| Drug distribution between blood and brain as a determinant of antipsychotic drug effects | Q48415314 | ||
| Distribution of chlorpromazine and imipramine in adipose and other tissues of rats | Q48714926 | ||
| ACOG Practice Bulletin No. 189: Nausea And Vomiting Of Pregnancy | Q50136134 | ||
| Distribution of chlorpromazine metabolites in selected organs of psychiatric patients chronically dosed up to the time of death. | Q52127337 | ||
| MERS-CoV pathogenesis and antiviral efficacy of licensed drugs in human monocyte-derived antigen-presenting cells. | Q54250885 | ||
| Chlorpromazine amplifies macrophage-dependent IL-10 production in vivo | Q60342761 | ||
| Test dose response in schizophrenia: chlorpromazine blood and saliva levels | Q67375036 | ||
| Rat tissue concentrations of chlorimipramine, chlorpromazine and their N-demethylated metabolites after a single oral dose of the parent compounds | Q70956146 | ||
| Pharmacological activities of chlorpromazine involved in the inhibition of tumour necrosis factor production in vivo in mice | Q72227813 | ||
| The distribution of 35S-chlorpromazine in mice studied by whole body autoradiography | Q72636037 | ||
| P921 | main subject | chlorpromazine | Q407972 |
| COVID-19 | Q84263196 | ||
| P577 | publication date | 2020-05-16 | |
| P1433 | published in | L'Encephale: revue de psychiatrie clinique biologique et therapeutique | Q3202945 |
| P1476 | title | [Repurposing chlorpromazine to treat COVID-19: the reCoVery study] |
| Q104613395 | Beyond the Surface: Endocytosis of Mosquito-Borne Flaviviruses |
| Q107473200 | SARS-CoV-2 infects cells after viral entry via clathrin-mediated endocytosis |
| Q98564396 | The current landscape of coronavirus-host protein-protein interactions |
Search more.